In these products, peptides are loaded within a PLGA polymer which slowly degrades in the body, allowing for sustained release of the therapeutic peptide
FDA labeling for stimulants recommends assessing for cardiac disease before starting therapy and monitoring vital signs
I think GLP-1 medications, in general, in some way sensitize cutaneous nerves or nerves of the skin and give people this reaction where they are hypersensitive to stimuli of the skin and causes the sensation in your brain of pain or burning or tingling or itching. Rosen maintained that the symptom can be mitigated by lowering the dosage and then gradually increasing it
If you need a specialist, Hello Alpha can refer you to someone local, but for just about anything from a persistent cough to mental health issues, Hello Alpha is just a few clicks away
10.1159/000480525 [DOI] [PMC free article] [PubMed] [Google Scholar] 3.Gatineau M et al (2014) Adult obesity and type 2 diabetes
Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association